Biotechnology in Surgery

Biotechnology in Surgery

von: Alfonso Barbarisi, Paolo Bechi, Paolo Innocenti, Carlo Alberto Redi, Francesco Rosso

Springer-Verlag, 2010

ISBN: 9788847016583 , 194 Seiten

Format: PDF

Kopierschutz: Wasserzeichen

Windows PC,Mac OSX für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's

Preis: 106,99 EUR

  • Thyroid Disease - A Case-Based and Practical Guide for Primary Care
    The Metabolic Syndrome in Clinical Practice
    CURED I - LENT Late Effects of Cancer Treatment on Normal Tissues
    Medical Technologies in Neurosurgery
    Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery
    Epiphyseal Growth Plate Fractures
  • Atherosclerosis and Oxidant Stress: A New Perspective
    Cell Signaling in Vascular Inflammation
    Mammakarzinom - Operative Behandlungskonzepte
    Brain Metastases
    Clinical Atlas of Interstitial Lung Disease
    Cardiology in Family Practice - A Practical Guide
 

Mehr zum Inhalt

Biotechnology in Surgery


 

Title Page

2

Copyright Page

3

Foreword

5

Preface

6

Table of Contents

8

1 The Philosophy of Biotechnology

16

1.1 Introduction

16

1.1.1 Genomics (fundamentals)

19

1.1.2 Proteomics (fundamentals)

20

1.1.3 Cell Therapy

21

1.1.4 Metabolomics: Potential Applications to Surgical Diseases F. Tarantini, M. Giannelli, D. Boni

22

1.2 The Role of the Surgeon in Translational Research

24

1.3 The Role of Biotechnology in Oncologic Surgery

25

References

28

2 New Approach to Diagnosis and Prognosis

30

2.1 Secondary Peritoneal Carcinomatosis and Biotechnology: a New Approach to Diagnosis and Therapy

30

2.1.1 Introduction

30

2.1.2 Pathophysiology

30

2.1.3 Future View to Diagnosis and Therapy

32

2.2 Pre-endothelial Cells and Prognosis of Intestinal Adenocarcinoma

33

2.2.1 Introduction

33

2.2.2 Endothelial Progenitor Cells and Post-natal Vasculogenesis

34

2.2.3 EPCs, Tumor Angiogenesis and Metastasis

34

2.2.4 EPCs as a Potential Biomarker for Tumor Angiogenesis

35

2.2.5 Molecular Markers of Tumor Angiogenesis and Antiangiogenic Drug Activity

37

2.2.6 EPC as Cellular Vehicles for Anticancer Therapy

37

2.2.7 Conclusions and Future Perspectives

37

2.3 Microarray Gene Expression of Pancreatic Carcinoma

38

2.3.1 Introduction

38

2.3.2 Microarray

39

2.3.3 Microarray and Pancreatic Cancer

40

2.3.4 Conclusions

41

2.4 The Significance of Circulating Tumor Cells as a Prognostic Marker for Colon Cancer: a New Biotechnology

42

2.4.1 Introduction

42

2.4.2 Personal Experience

43

2.4.3 Conclusions

44

2.5 Advanced Diagnostic Applications

45

2.5.1 Introduction

45

2.5.2 Immunogold Labeling

45

2.5.3 Thyroid Lesion

46

2.5.4 Galectin-3 and Tumors

46

2.5.5 Our Experience

47

2.5.6 Conclusions

50

References

50

3 Biomolecular Staging: Reality or Future Perspective?

56

3.1 Introduction

56

3.1.1 Apoptosis Related Genes

57

3.1.2 Oncogenes

58

3.1.3 Inhibitors of Cyclin Dependent Kinases (Cdk)

58

3.1.4 Adhesion Molecule Expression

59

3.1.5 Flow Cytometry DNA Content

59

3.1.6 Conclusions

60

3.2 Molecular Biology as the Identity Card of Human Tumors

60

3.3 Interventional Timing According to New Insights in Basic Research

65

3.4 Cellular Biology: A Way of Predicting Cancerogenic Progression, Prognosis and Response to Adjuvant Treatment

68

References

72

4 Technology for Biotechnology

75

4.1 Nanotechnology and Nanofabrication

75

4.2 Biosensors

80

4.3 Nanodiagnostics

83

References

86

5 Regenerative Medicine: Current and Potential Applications

88

5.1 Scaffold and Molecular Signals for Tissue Engineering

88

5.2 Cell Source for Tissue Engineering

90

5.3 Skin

95

5.4 Lung Epithelium

97

5.5 The Bioartificial Liver

99

5.5.1 Introduction

99

5.5.2 Bioartificial Technical Support

100

5.5.3 BAL Structure

100

5.5.4 Clinical-Laboratory Parameters Assessed

101

5.5.5 Clinical Trials

102

5.5.6 Conclusions

103

References

104

6 In Vivo Imaging of Regenerated Tissue: State of Art and Future Perspectives

108

6.1 Introduction

108

6.2 Conventional Imaging of Regenerated Tissue

109

6.3 Molecular Imaging of Regenerated Tissue

111

6.3.1 MRI Molecular Imaging: Contrast Agents and Reporter Genes

112

6.4 Conclusions

114

References

114

7 Biotechnological Approaches to Hemostasis and Molecular Mechanisms of Wound Healing

117

7.1 Biotechnology for Hemostasis Control

117

7.2 Hemostatic Agents and their Mechanism of Action

118

7.2.1 Collagen and Gelatin Sponges

119

7.2.2 Oxidized Cellulose

121

7.2.3 Fibrin Glue

121

7.2.4 Synthetic Sealants and Adhesives

123

7.2.5 The Future: Innovative Biotechnology for Hemostasis Control

124

References

125

8 Gene Therapy

127

8.1 Gene Therapy

127

8.2 Gene Therapy for Neurodegenerative Diseases

131

8.3 Local Gene Delivery for Tissue Repair in Surgery

135

8.3.1 Introduction

135

8.3.2 Barriers to the Delivery of Genes for Tissue Repair In Vivo

136

8.3.3 Viral Vectors

136

8.3.4 Non-viral Vectors

137

8.3.5 Tissue Engineering Scaffolds

138

8.3.6 Conclusions

138

References

139

9 Stem Cells

143

9.1 Philosophical and Lexical Issues

143

9.2 Origin, Animal and Vegetal Models

145

9.3 Somatic and Embryonic Stem Cells

146

9.4 Stemness Genes

151

9.5 Induction of Pluripotency

152

9.6 Stem Cells in Regenerative Medicine

154

9.7 International Legal Framework: Stem Cell Biopolitics and Scientific Citizenship

155

References

159

10 Cancer Stem Cells

162

10.1 Origin and Evolution of the Cancer Stem Cell Paradigm

162

10.2 Functional Genomics of CSCs

163

10.3 Molecular Biology of CSCs

164

10.4 CSCs and Carcinogenesis

165

10.5 CSCs and Tumor Recurrence

166

10.6 CSC and Metastases

167

10.7 In Vivo Imaging of CSCs

169

10.8 CSCs and Colon Cancer

170

10.9 Breast Cancer and CSCs

171

10.10 CSCs and Ovarian Cancer

172

10.11 CSCs and Lung Cancer

173

10.12 CSCs and Pancreatic Adenocarcinoma

174

10.13 CSCs and Prostate Cancer

175

10.14 CSCs and Glioblastoma Multiforme

176

10.15 Eradication of CSCs

177

References

178

Appendix The Impact on Surgical Practice of Recent Advances in Biotechnology. Interactions Between Inherited and Environmental Factors in the Occurrence - and Biological Behavior - of Diseases of Surgical Interest

180

Lesson from Inherited Multitumoral Syndromes

180

Lesson from Inherited Multitumoral Syndromes Including Early Aging

183

Lesson from Hepatobiliary and Pancreatic Malignancies

185

Lesson from Liver Regeneration

185

Lesson from Genetics and Genetic Engineering or Advances in Biotechnology: Surgical Implications

187

Lesson from Pollution Related Diseases

188

Lesson from In Vitro Studies of Airborne Pollutants on Synoviocytes and Sperm Cells

189

Lesson from Asbestos Exposure and Mesothelioma in Humans

190

Suggestions to Policy Makers to Tackle Health Effects from Air Pollution

196

Lesson from Epidemiologic and Genome-wide Association Studies

196

Conclusions

198

References

199

Subject Index

202